JPI Healthcare제이피아이헬스케어
0010V0 · KOSDAQ · ₩0010V0 · 제이피아이헬스케어
Valuation model · Discounted cash flow (DCF)
We use a 5-year discounted cash flow: the value of the cash the business is expected to produce, in today's money.
Fair value per share
₩15,621
vs the current price (₩7,770)
- Enterprise value
- ₩58B
- Equity value
- ₩80B
- WACC
- 7.3%
Model estimate based on the assumptions shown. Not a price target and not a buy or sell signal. This is not financial advice.
Why the model and the price differ
The model is 101% away from today's price. A gap this size usually means the market expects something the past figures don't show yet, or the model leaves something out. What we can see:
- To match today's price of ₩7,770, the model needs an operating margin of 4.1% every year (it uses 10.0%).
- 52% of the last 12 months' net profit came from outside operations (stakes in other companies, interest, one-offs). The model adds those stakes at book value but doesn't project that income.
Treat the model as a starting point: change the assumptions to the story you believe, and compare with the multiples check below.
Bear / Base / Bull
- Bear
- ₩11,059
- +42.3%
- Base
- ₩15,621
- +101.0%
- Bull
- ₩23,587
- +203.6%
Bear: revenue growth 3 points lower every year, EBIT margin 2 points lower, WACC 1 point higher. Bull: the opposite.
Assumptions
Sign in to change the assumptions and see the results update. Sign in
Cycle options
Margin path
Every year uses the cycle-average margin (10.0%).
Revenue growth
- 3%
How much sales grow that year, compared with the year before.
Default: not enough revenue history, so 3%.
- 3%
How much sales grow that year, compared with the year before.
Default: not enough revenue history, so 3%.
- 3%
How much sales grow that year, compared with the year before.
Default: not enough revenue history, so 3%.
- 3%
How much sales grow that year, compared with the year before.
Default: not enough revenue history, so 3%.
- 3%
How much sales grow that year, compared with the year before.
Default: not enough revenue history, so 3%.
Business
- 10%
Operating profit as a share of revenue.
Default: through-the-cycle average of the last 12 months and the last 1 annual reports' operating margins.
- 27.5%
Share of operating profit paid as corporate tax.
Default: Korea's top corporate tax rate (25%) plus 10% local income tax.
- 1.9%
The non-cash cost of wearing out equipment, added back to cash flow (% of revenue).
Default: not in the statements, so 80% of capital spending (most spending replaces equipment that wears out).
- 2.4%
Money spent on factories, equipment, software and other long-term assets (% of revenue).
Default: average of the last 1 annual reports (cash flow statements; equipment and intangibles).
- 39.4%
Stock and unpaid customer bills, less unpaid supplier bills, as a % of revenue. Each year's extra revenue ties up this much more cash.
Default: working capital (current assets less cash and deposits, minus current liabilities other than borrowings) as a share of revenue, averaged over the last 1 years.
Discount rate
- 2%
How fast cash flows keep growing every year after year 5.
Default: about Korea's long-run inflation plus real growth.
- 4.01%
Yield on Korea's 10-year government bond: the return with almost no risk.
Default: Korea Treasury Bond 10-year yield on 2026-10-30.
- 0.6
How much the share moves when the market moves: 1 means just like the market.
Default: 62 weeks of weekly returns against KOSPI (official index); raw beta -0.01, adjusted toward 1 and kept between 0.6 and 2.0.
- 5.5%
The extra return investors want for owning shares instead of bonds.
Default: a typical premium for Korean shares.
- 5.51%
The interest rate the company would pay to borrow.
Default: the 10-year yield plus a 1.5% credit spread.
Starting point
- Revenue (TTM to H1 2026)
- ₩47B
- Net debt (borrowings and leases − cash and deposits)
- −₩22B
- + Stakes and investments
- ₩2.5M
- Associates, long-term financial assets and deposits (book value)
- Shares
- 5,105,400
- Share price
- ₩7,770
- Market cap
- ₩40B
TTM = trailing 12 months: the last four reported quarters added together. "TTM to H1 2026" is the 12 months up to the latest quarterly or half-year report (H1 = to the end of June). Year 1 grows from there.
Past years and projection
Grey columns are reported results from the annual reports (after-tax EBIT at the model's tax rate), so you can check the growth and margin assumptions against the past. Years 1–5 are the model.
| FY2025 | Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | |
|---|---|---|---|---|---|---|
| Revenue | ₩48B | ₩48B | ₩50B | ₩51B | ₩53B | ₩54B |
| Growth | — | 3.0% | 3.0% | 3.0% | 3.0% | 3.0% |
| EBIT | ₩4.9B | ₩4.8B | ₩5B | ₩5.1B | ₩5.3B | ₩5.4B |
| EBIT margin | 10.0% | 10.0% | 10.0% | 10.0% | 10.0% | 10.0% |
| After-tax EBIT | ₩3.5B | ₩3.5B | ₩3.6B | ₩3.7B | ₩3.8B | ₩3.9B |
| + Depreciation | — | ₩917M | ₩945M | ₩973M | ₩1B | ₩1B |
| − Capital spending | ₩1.2B | ₩1.2B | ₩1.2B | ₩1.2B | ₩1.3B | ₩1.3B |
| − Working capital | — | ₩554M | ₩571M | ₩588M | ₩605M | ₩623M |
| Free cash flow | — | ₩2.7B | ₩2.8B | ₩2.9B | ₩3B | ₩3B |
| Discount factor | — | 0.932 | 0.868 | 0.809 | 0.754 | 0.703 |
| Present value | — | ₩2.5B | ₩2.4B | ₩2.3B | ₩2.2B | ₩2.1B |
Terminal value ₩65B, worth ₩46B today: 80% of enterprise value. It assumes spending settles at 110% of depreciation once growth slows to the terminal rate.
Sensitivity
Fair value per share as two inputs change; the middle is the current case.
| WACC ↓ · Terminal growth → | 1.0% | 1.5% | 2.0% | 2.5% | 3.0% |
|---|---|---|---|---|---|
| 6.3% | ₩16,612 | ₩17,374 | ₩18,309 | ₩19,486 | ₩21,014 |
| 6.8% | ₩15,513 | ₩16,109 | ₩16,825 | ₩17,704 | ₩18,810 |
| 7.3% | ₩14,590 | ₩15,062 | ₩15,621 | ₩16,293 | ₩17,118 |
| 7.8% | ₩13,803 | ₩14,183 | ₩14,625 | ₩15,149 | ₩15,778 |
| 8.3% | ₩13,125 | ₩13,433 | ₩13,788 | ₩14,202 | ₩14,691 |
Now (TTM)
- Market cap
- ₩40B
- Enterprise value
- ₩18B
- P/E
- 5.6×
- P/B
- 0.6×
- P/S
- 0.8×
- EV/EBITDA
- —
- Dividend yield
- 3.2%
Over time (at each year end)
| 2025 | |
|---|---|
| Price | ₩14,300 |
| Market cap | ₩73B |
| P/E | 13.9× |
| P/B | 1.1× |
| P/S | 1.5× |
| EV/EBITDA | — |
| Dividend yield | 1.7% |
Versus similar companies
| Company | P/E | P/B | P/S | EV/EBITDA | Dividend yield |
|---|---|---|---|---|---|
| JPI Healthcare | 5.6× | 0.6× | 0.8× | — | 3.2% |
| TSE | 27.5× | 6.1× | 5.1× | — | 0.2% |
| Kctech | 22.1× | 3.4× | 4.1× | 17.1× | 0.5% |
| Classys | 12.7× | 3.2× | 4.7× | 9.9× | 3.7% |
| Park Systems | 69.0× | 4.7× | 8.2× | — | 0.2% |
| DI | 42.2× | 5.8× | 2.6× | — | 0.6% |
| Curiox Biosystems | — | 21.3× | 182.0× | — | 0.0% |
| Similar companies (median) | 27.5× | 5.3× | 4.9× | 13.5× | 0.3% |
Calculated from end-of-day prices and filed financial statements. Not a recommendation. This is not financial advice.
Also known as: JPI Healthcare / 제이피아이헬스케어 / 0010V0 / KRX:0010V0
Source: KRX statistical information